Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

155
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
155
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

810
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
810
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

120
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
120
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

614
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
614

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning layer-specific collagen quantification correlates with activity and is associated with outcomes in Crohn's disease.

Journal of Crohn's & colitis·2026
Same author

Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology.

Gut·2026
Same author

Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohort.

Inflammatory bowel diseases·2026
Same author

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The lancet. Gastroenterology & hepatology·2026
Same author

Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Disordered Bile Acid Metabolism in Alcohol-Related Hepatitis.

Alimentary pharmacology & therapeutics·2026
Same journal

Lactate Metabolism Dysregulation Drives the Pathogenesis of Acute Kidney Injury.

Metabolites·2026
Same journal

Librarian: An Open-Access Web Application for High-Resolution Mass Spectral Library Assembly.

Metabolites·2026
Same journal

Purine Metabolism Alterations in Patients with Chronic Heart Failure: A Cross-Sectional Study of Associations with Iron Status, Oxidative Stress, and Anemia.

Metabolites·2026
Same journal

The Gut Microbiome in Heart Failure: Pathways to Inflammation and Therapeutic Targets.

Metabolites·2026
Same journal

Metabolic Mechanisms of Hexavalent Chromium-Induced Splenic Immune Injury via Oxidative Stress and Ferroptosis Pathways in New Zealand Rabbits.

Metabolites·2026
Same journal

Improving Speed and Efficiency of DESI Imaging with the Xevo MRT Mass Spectrometer for Analyte Mapping.

Metabolites·2026
See all related articles

Related Experiment Video

Updated: Aug 1, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Screening for NAFLD-Current Knowledge and Challenges.

Roberta Forlano1, Giordano Sigon1, Benjamin H Mullish1

  • 1Liver Unit, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London W21NY, UK.

Metabolites
|April 28, 2023
PubMed
Summary
This summary is machine-generated.

Non-alcoholic fatty liver disease (NAFLD) affects nearly half the population and may soon lead to end-stage liver disease. Early detection in primary care is crucial but faces challenges with current screening methods.

Keywords:
liver fibrosisnon-alcoholic fatty liver diseaseprimary carescreening

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

979
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.0K

Related Experiment Videos

Last Updated: Aug 1, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

979
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.0K

Area of Science:

  • Hepatology
  • Gastroenterology
  • Primary Care Medicine

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of abnormal liver function tests globally.
  • NAFLD prevalence ranges from 19-46%, posing a significant public health concern.
  • The condition is projected to become a leading cause of end-stage liver disease.

Purpose of the Study:

  • To review current knowledge on NAFLD screening in primary care.
  • To identify limitations and uncertainties in developing a NAFLD screening policy.
  • To highlight challenges in early NAFLD detection, particularly in high-risk groups.

Main Methods:

  • Literature review of current NAFLD screening strategies.
  • Analysis of non-invasive fibrosis markers and their limitations.
  • Examination of cost-effectiveness and treatment availability for NAFLD.

Main Results:

  • Significant uncertainties exist regarding NAFLD screening policy development.
  • Limitations in non-invasive fibrosis markers hinder accurate early detection.
  • The absence of a licensed treatment complicates screening decisions.

Conclusions:

  • Early NAFLD detection in primary care is of high interest due to disease prevalence and severity.
  • Current screening approaches face substantial limitations.
  • Further research is needed to refine NAFLD screening policies.